Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Organ-on-a-Chip Europe 2016

Lars Sundstrom's Biography



Lars Sundstrom, Professor of Practice in Translational Medicine, Elizabeth Blackwell Institute for Health Research, Bristol University

Prof. Lars Sundstrom is Professor of Practice in Translational Medicine at Bristol University and also Director of Enterprise and Translation at the West of England Academic Health Sciences Network. He is also and an honorary Professor of Medcine at Cardiff University. Lars has 30 years experience working in translational medicine at the Universities of Bristol Cardiff, Southampton, Bordeaux , Oxford and several years working in industry developing new therapeutics and tools for drug discovery. Lars has held executive and board level positions in several SMEs and has also been an advisor to several UK wide and European Commission led groups, on in-vitro alternatives to animal models. In 2002-2012 he was Chief Scientific Officer at Capsant Technologies LTD, one of the first companies to commercially developing 3D Tissue models for drug discover applications based on reconstituted human primary tissues and human Stem cells. Since 2009 he has been involved in building translational networks with the NHS, universities with industry at a regional level in the west of the UK. In 2009 he set up led the Severnside Alliance for Translational Research (SARTRE) a devolved funding scheme supported by the MRC and the Welsh Govt and in 2012 he co-founded the Elizabeth Blackwell Institute for Health research at Bristol University, In 2013 he took up the role as Director of Enterprise in the West of England Academic Health Sciences Network (funded by NHS England). Lars also currently chairs the Health Sector group of the West of England Local Enterprise Partnership.

Lars Sundstrom Image

Organ-on-a-chip – Are We There Yet?

Tuesday, 5 April 2016 at 09:00

Add to Calendar ▼2016-04-05 13:58:002016-04-05 14:58:00Europe/LondonSession Title: Organs-on-a-Chip - Research to CommercialisationOrgan-on-a-Chip Europe 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

It was suggested over a decade ago that the ERA of Flat Biology (2D Tissue culture) would soon be over and that 3 dimensional ‘Organotypic’ systems would become the dominant in-vitro model for drug profiling. While we have made huge technical advances in methods of producing reliable 3D systems from both Stem Cells and Primary tissues these are not yet mainstream. Along with advances in microfluidics we could be equally bold and suggest the time has come for new ‘Organ on a Chip’ systems to replace in-vivo alternatives. In this presentation I’d like to explore translational aspects and explore where barriers still exist that might inhibit up take of such systems and prevent their widespread acceptance by the research community and by Industry.

Session Title: Organs-on-a-Chip - Research to Commercialisation

Tuesday, 5 April 2016 at 13:58

Add to Calendar ▼2016-04-05 13:58:002016-04-05 14:58:00Europe/LondonSession Title: Organs-on-a-Chip - Research to CommercialisationOrgan-on-a-Chip Europe 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2016-04-05 00:00:002016-04-06 00:00:00Europe/LondonOrgan-on-a-Chip Europe 2016Organ-on-a-Chip Europe 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com